A novel self-lipid antigen targets human T cells against CD1c+ leukemias

Journal of Experimental Medicine

Volumn 211, Issue 7, 2014, Pages 1363-1377

  Lepore, Marco ^a,d   de Lalla, Claudia ^d   Gundimeda, Ramanjaneyulu ^a   Gsellinger, Heiko ^b   Consonni, Michela ^d   Garavaglia, Claudio ^d   Sansano, Sebastiano ^a   Piccolo, Francesco ^d   Scelfo, Andrea ^d   Häussinger, Daniel ^b   Montagna, Daniela ^e   Locatelli, Franco ^f   Bonini, Chiara ^d   Bondanza, Attilio ^d   Forcina, Alessandra ^d   Li, Zhiyuan ^g   Ni, Guanghui ^g   Ciceri, Fabio ^d   Jenö, Paul ^c   Xia, Chengfeng ^g   Mori, Lucia ^a,h   dellabona, Paolo ^d   Casorati, Giulia ^d   de Libero, Gennaro ^a,h   more..

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^g KUNMING INSTITUTE OF BOTANY   (China)

^h AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD1C ANTIGEN; LYSOPHOSPHATIDIC ACID;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B CELL LEUKEMIA; CELL POLARITY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC CELL; HETERONUCLEAR MULTIPLE BOND CORRELATION; HETERONUCLEAR SINGLE QUANTUM COHERENCE; HUMAN; HUMAN CELL; IMMUNOGENICITY; IMMUNOSURVEILLANCE; IN VIVO STUDY; LEUKEMIA CELL; LEUKEMIA CELL LINE; MOUSE; NONHUMAN; NUCLEAR OVERHAUSER EFFECT; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; TUMOR CELL LINE;

ADOLESCENT; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; AUTOANTIGENS; BLAST CRISIS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC SURVEILLANCE; JURKAT CELLS; LEUKEMIA, MYELOID, ACUTE; LYSOPHOSPHOLIPIDS; MALE; MICE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; T-LYMPHOCYTES;

EID: 84903754024     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20140410     Document Type: Article

References (66)

1. Amprey, J.L., J.S. Im, S.J. Turco, H.W. Murray, P.A. Illarionov, G.S. Besra, S.A. Porcelli, and G.F. Späth. 2004. A subset of liver NK T cells is activated during Leishmania donovani infection by CD1d-bound lipophosphoglycan. J. Exp. Med. 200:895-904. http://dx.doi.org/10.1084/jem.20040704
2. Berzofsky, J.A., and M. Terabe. 2009. The contrasting roles of NKT cells in tumor immunity. Curr. Mol. Med. 9:667-672. http://dx.doi.org/10.2174/156652409788970706
3. Bondanza, A., V. Valtolina, Z. Magnani, M. Ponzoni, K. Fleischhauer, M. Bonyhadi, C. Traversari, F. Sanvito, S. Toma, M. Radrizzani, et al. 2006. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytes. Blood. 107:1828-1836. http://dx.doi.org/10.1182/blood-2005-09-3716
4. Boon, T., P.G. Coulie, B.J. Van den Eynde, and P. van der Bruggen. 2006. Human T cell responses against melanoma. Annu. Rev. Immunol. 24:175-208. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090733
5. Brigl, M., and M.B. Brenner. 2004. CD1: antigen presentation and T cell function. Annu. Rev. Immunol. 22:817-890. http://dx.doi.org/10.1146/annurev.immunol.22.012703.104608
6. Canderan, G., P. Gruarin, D. Montagna, R. Fontana, G. Campi, G. Melloni, C. Traversari, P. Dellabona, and G. Casorati. 2010. An efficient strategy to induce and maintain in vitro human T cells specific for autologous non-small cell lung carcinoma. PLoS ONE. 5:e12014. (published erratum appears in PLoS ONE. 2011. 6:10.1371/annotation/df559170-4836-4bc7-a16d-44c7c6339cda) http://dx.doi.org/10.1371/journal.pone.0012014
7. Cerundolo, V., J.D. Silk, S.H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9:28-38. http://dx.doi.org/10.1038/nri2451
8. Cha, M.K., K.H. Suh, and I.H. Kim. 2009. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J. Exp. Clin. Cancer Res. 28:93. http://dx.doi.org/10.1186/1756-9966-28-93
9. Chang, D.H., H. Deng, P. Matthews, J. Krasovsky, G. Ragupathi, R. Spisek, A. Mazumder, D.H. Vesole, S. Jagannath, and M.V. Dhodapkar. 2008. Inflammation-associated lysophospholipids as ligands for CD1d-restricted T cells in human cancer. Blood. 112:1308-1316. http://dx.doi.org/10.1182/blood-2008-04-149831
10. Ciceri, F., C. Bonini, M.T. Stanghellini, A. Bondanza, C. Traversari, M. Salomoni, L. Turchetto, S. Colombi, M. Bernardi, J. Peccatori, et al. 2009. Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. Lancet Oncol. 10:489-500. http://dx.doi.org/10.1016/S1470-2045(09)70074-9
11. de Jong, A., V. Peña-Cruz, T.Y. Cheng, R.A. Clark, I. Van Rhijn, and D.B. Moody. 2010. CD1a-autoreactive T cells are a normal component of the human ΑΒ T cell repertoire. Nat. Immunol. 11:1102-1109. http://dx.doi.org/10.1038/ni.1956
12. de Lalla, C., M. Lepore, F.M. Piccolo, A. Rinaldi, A. Scelfo, C. Garavaglia, L. Mori, G. De Libero, P. Dellabona, and G. Casorati. 2011. High-frequency and adaptive-like dynamics of human CD1 self-reactive T cells. Eur. J. Immunol. 41:602-610. http://dx.doi.org/10.1002/eji.201041211
13. De Libero, G., A.P. Moran, H.J. Gober, E. Rossy, A. Shamshiev, O. Chelnokova, Z. Mazorra, S. Vendetti, A. Sacchi, M.M. Prendergast, et al. 2005. Bacterial infections promote T cell recognition of self-glycolipids. Immunity. 22:763-772. http://dx.doi.org/10.1016/j.immuni.2005.04.013
14. Dellabona, P., G. Casorati, B. Friedli, L. Angman, F. Sallusto, A. Tunnacliffe, E. Roosneek, and A. Lanzavecchia. 1993. In vivo persistence of expanded clones specific for bacterial antigens within the human T cell receptor alpha/beta CD4-8- subset. J. Exp. Med. 177:1763-1771. http://dx.doi.org/10.1084/jem.177.6.1763
15. Dhodapkar, M.V., and J. Richter. 2011. Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges. Clin. Immunol. 140: 160-166. http://dx.doi.org/10.1016/j.clim.2010.12.010
16. Döhner, H., E.H. Estey, S. Amadori, F.R. Appelbaum, T. Büchner, A.K. Burnett, H. Dombret, P. Fenaux, D. Grimwade, R.A. Larson, et al. European LeukemiaNet. 2010. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 115:453-474. http://dx.doi.org/10.1182/blood-2009-07-235358
17. Dorsam, R.T., and J.S. Gutkind. 2007. G-protein-coupled receptors and cancer. Nat. Rev. Cancer. 7:79-94. http://dx.doi.org/10.1038/nrc2069
18. Doulatov, S., F. Notta, E. Laurenti, and J.E. Dick. 2012. Hematopoiesis: a human perspective. Cell Stem Cell. 10:120-136. http://dx.doi.org/10.1016/j.stem.2012.01.006
19. Endo, T., K. Kano, R. Motoki, K. Hama, S. Okudaira, M. Ishida, H. Ogiso, M. Tanaka, N. Matsuki, R. Taguchi, et al. 2009. Lysophosphatidylmethanol is a pan lysophosphatidic acid receptor agonist and is produced by autotaxin in blood. J. Biochem. 146:283-293. http://dx.doi.org/10.1093/jb/mvp068
20. Facciotti, F., G.S. Ramanjaneyulu, M. Lepore, S. Sansano, M. Cavallari, M. Kistowska, S. Forss-Petter, G. Ni, A. Colone, A. Singhal, et al. 2012. Peroxisome-derived lipids are self antigens that stimulate invariant natural killer T cells in the thymus. Nat. Immunol. 13:474-480. http://dx.doi.org/10.1038/ni.2245
21. Garcia-Alles, L.F., K. Versluis, L. Maveyraud, A.T. Vallina, S. Sansano, N.F. Bello, H.J. Gober, V. Guillet, H. de la Salle, G. Puzo, et al. 2006. Endogenous phosphatidylcholine and a long spacer ligand stabilize the lipid-binding groove of CD1b. EMBO J. 25:3684-3692. http://dx.doi.org/10.1038/sj.emboj.7601244
22. Gilleron, M., S. Stenger, Z. Mazorra, F. Wittke, S. Mariotti, G. Böhmer, J. Prandi, L. Mori, G. Puzo, and G. De Libero. 2004. Diacylated sulfoglycolipids are novel mycobacterial antigens stimulating CD1-restricted T cells during infection with Mycobacterium tuberculosis. J. Exp. Med. 199:649-659. http://dx.doi.org/10.1084/jem.20031097
23. Gumperz, J.E., C. Roy, A. Makowska, D. Lum, M. Sugita, T. Podrebarac, Y. Koezuka, S.A. Porcelli, S. Cardell, M.B. Brenner, and S.M. Behar. 2000. Murine CD1d-restricted T cell recognition of cellular lipids. Immunity. 12:211-221. http://dx.doi.org/10.1016/S1074-7613(00)80174-0
24. Han, X., and R.W. Gross. 1996. Structural determination of lysophospholipid regioisomers by electrospray ionization tandem mass spectrometry. J. Am. Chem. Soc. 118:451-457. http://dx.doi.org/10.1021/ja952326r
25. Hsu, F.F., and J. Turk. 2007. Differentiation of 1-O-alk-1'-enyl-2-acyl and 1-O-alkyl-2-acyl glycerophospholipids by multiple-stage linear ion-trap mass spectrometry with electrospray ionization. J. Am. Soc. Mass Spectrom. 18:2065-2073. http://dx.doi.org/10.1016/j.jasms.2007.08.019
26. Hsu, P.P., and D.M. Sabatini. 2008. Cancer cell metabolism: Warburg and beyond. Cell. 134:703-707. http://dx.doi.org/10.1016/j.cell.2008.08.021
27. Jäger, D., E. Jäger, and A. Knuth. 2001. Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol. 54:669-674. http://dx.doi.org/10.1136/jcp.54.9.669
28. Jedema, I., N.M. van der Werff, R.M. Barge, R. Willemze, and J.H. Falkenburg. 2004. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood. 103:2677-2682. http://dx.doi.org/10.1182/blood-2003-06-2070
29. Kinjo, Y., D. Wu, G. Kim, G.W. Xing, M.A. Poles, D.D. Ho, M. Tsuji, K. Kawahara, C.H. Wong, and M. Kronenberg. 2005. Recognition of bacterial glycosphingolipids by natural killer T cells. Nature. 434:520-525. http://dx.doi.org/10.1038/nature03407
30. Kolb, H.J. 2008. Graft-versus-leukemia effects of transplantation and donor lymphocytes. Blood. 112:4371-4383. http://dx.doi.org/10.1182/blood-2008-03-077974
31. Manolova, V., Y. Hirabayashi, L. Mori, and G. De Libero. 2003. CD1a and CD1b surface expression is independent from de novo synthesized glycosphingolipids. Eur. J. Immunol. 33:29-37. http://dx.doi.org/10.1002/immu.200390004
32. Matsushita, H., M.D. Vesely, D.C. Koboldt, C.G. Rickert, R. Uppaluri, V.J. Magrini, C.D. Arthur, J.M. White, Y.S. Chen, L.K. Shea, et al. 2012. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature. 482:400-404. http://dx.doi.org/10.1038/nature10755
33. Mattner, J., K.L. Debord, N. Ismail, R.D. Goff, C. Cantu III, D. Zhou, P. Saint-Mezard, V. Wang, Y. Gao, N. Yin, et al. 2005. Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature. 434:525-529. http://dx.doi.org/10.1038/nature03408
34. Metelitsa, L.S. 2011. Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin. Immunol. 140:119-129. http://dx.doi.org/10.1016/j.clim.2010.10.005
35. Mills, G.B., and W.H. Moolenaar. 2003. The emerging role of lysophosphatidic acid in cancer. Nat. Rev. Cancer. 3:582-591. http://dx.doi.org/10.1038/nrc1143
36. Montagna, D., R. Maccario, F. Locatelli, E. Montini, S. Pagani, F. Bonetti, L. Daudt, I. Turin, D. Lisini, C. Garavaglia, et al. 2006. Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood. 108:3843-3850. http://dx.doi.org/10.1182/blood-2006-05-021535
37. Montamat-Sicotte, D.J., K.A. Millington, C.R. Willcox, S. Hingley-Wilson, S. Hackforth, J. Innes, O.M. Kon, D.A. Lammas, D.E. Minnikin, G.S. Besra, et al. 2011. A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection. J. Clin. Invest. 121:2493-2503. http://dx.doi.org/10.1172/JCI46216
38. Moody, D.B., T. Ulrichs, W. Mühlecker, D.C. Young, S.S. Gurcha, E. Grant, J.P. Rosat, M.B. Brenner, C.E. Costello, G.S. Besra, and S.A. Porcelli. 2000. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection. Nature. 404:884-888. http://dx.doi.org/10.1038/35009119
39. Moody, D.B., D.C. Young, T.Y. Cheng, J.P. Rosat, C. Roura-Mir, P.B. O'Connor, D.M. Zajonc, A. Walz, M.J. Miller, S.B. Levery, et al. 2004. T cell activation by lipopeptide antigens. Science. 303:527-531. http://dx.doi.org/10.1126/science.1089353
40. Nomura, D.K., J.Z. Long, S. Niessen, H.S. Hoover, S.W. Ng, and B.F. Cravatt. 2010. Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell. 140:49-61. http://dx.doi.org/10.1016/j.cell.2009.11.027
41. Nowbakht, P., M.C. Ionescu, A. Rohner, C.P. Kalberer, E. Rossy, L. Mori, D. Cosman, G. De Libero, and A. Wodnar-Filipowicz. 2005. Ligands for natural killer cell-activating receptors are expressed upon the maturation of normal myelomonocytic cells but at low levels in acute myeloid leukemias. Blood. 105:3615-3622. http://dx.doi.org/10.1182/blood-2004-07-2585
42. Porcelli, S.A., and R.L. Modlin. 1999. The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids. Annu. Rev. Immunol. 17:297-329. http://dx.doi.org/10.1146/annurev.immunol.17.1.297
43. Provasi, E., P. Genovese, A. Lombardo, Z. Magnani, P.Q. Liu, A. Reik, V. Chu, D.E. Paschon, L. Zhang, J. Kuball, et al. 2012. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat. Med. 18:807-815. http://dx.doi.org/10.1038/nm.2700
44. Pui, C.H., M.V. Relling, and J.R. Downing. 2004. Acute lymphoblastic leukemia. N. Engl. J. Med. 350:1535-1548. http://dx.doi.org/10.1056/NEJMra023001
45. Pui, C.H., W.L. Carroll, S. Meshinchi, and R.J. Arceci. 2011. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J. Clin. Oncol. 29:551-565. http://dx.doi.org/10.1200/JCO.2010.30.7405
46. Pulfer, M., and R.C. Murphy. 2003. Electrospray mass spectrometry of phospholipids. Mass Spectrom. Rev. 22:332-364. http://dx.doi.org/10.1002/mas.10061
47. Rubnitz, J.E., B. Gibson, and F.O. Smith. 2008. Acute myeloid leukemia. Pediatr. Clin. North Am. 55:21-51: ix (ix.). http://dx.doi.org/10.1016/j.pcl.2007.11.003
48. Schrader, M., and H.D. Fahimi. 2006. Peroxisomes and oxidative stress. Biochim. Biophys. Acta. 1763:1755-1766. http://dx.doi.org/10.1016/j.bbamcr.2006.09.006
49. Seremet, T., F. Brasseur, and P.G. Coulie. 2011. Tumor-specific antigens and immunologic adjuvants in cancer immunotherapy. Cancer J. 17:325-330. http://dx.doi.org/10.1097/PPO.0b013e3182326004
50. Shamshiev, A., A. Donda, I. Carena, L. Mori, L. Kappos, and G. De Libero. 1999. Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29:1667-1675. http://dx.doi.org/10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U
51. Shamshiev, A., A. Donda, T.I. Prigozy, L. Mori, V. Chigorno, C.A. Benedict, L. Kappos, S. Sonnino, M. Kronenberg, and G. De Libero. 2000. The αβ T cell response to self-glycolipids shows a novel mechanism of CD1b loading and a requirement for complex oligosaccharides. Immunity. 13: 255-264. http://dx.doi.org/10.1016/S1074-7613(00)00025-X
52. Shamshiev, A., H.J. Gober, A. Donda, Z. Mazorra, L. Mori, and G. De Libero. 2002. Presentation of the same glycolipid by different CD1 molecules. J. Exp. Med. 195:1013-1021. http://dx.doi.org/10.1084/jem.20011963
53. Socié, G., and B.R. Blazar. 2009. Acute graft-versus-host disease: from the bench to the bedside. Blood. 114:4327-4336. http://dx.doi.org/10.1182/blood-2009-06-204669
54. Speiser, D.E., and P. Romero. 2010. Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity. Semin. Immunol. 22: 144-154. http://dx.doi.org/10.1016/j.smim.2010.03.004
55. Sriram, V., W. Du, J. Gervay-Hague, and R.R. Brutkiewicz. 2005. Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur. J. Immunol. 35:1692-1701. http://dx.doi.org/10.1002/eji.200526157
56. Vago, L., S.K. Perna, M. Zanussi, B. Mazzi, C. Barlassina, M.T. Stanghellini, N.F. Perrelli, C. Cosentino, F. Torri, A. Angius, et al. 2009. Loss of mismatched HLA in leukemia after stem-cell transplantation. N. Engl. J. Med. 361:478-488. http://dx.doi.org/10.1056/NEJMoa0811036
57. van Meeteren, L.A., and W.H. Moolenaar. 2007. Regulation and biological activities of the autotaxin-LPA axis. Prog. Lipid Res. 46:145-160. http://dx.doi.org/10.1016/j.plipres.2007.02.001
58. Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson. 2009. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 324:1029-1033. http://dx.doi.org/10.1126/science.1160809
59. Vidriales, M.B., J.J. Pérez, M.C. López-Berges, N. Gutiérrez, J. Ciudad, P. Lucio, L. Vazquez, R. García-Sanz, M.C. del Cañizo, J. Fernández-Calvo, et al. 2003. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value. Blood. 101:4695-4700. http://dx.doi.org/10.1182/blood-2002-08-2613
60. Vincent, M.S., D.S. Leslie, J.E. Gumperz, X. Xiong, E.P. Grant, and M.B. Brenner. 2002. CD1-dependent dendritic cell instruction. Nat. Immunol. 3:1163-1168. http://dx.doi.org/10.1038/ni851
61. Vincent, M.S., X. Xiong, E.P. Grant, W. Peng, and M.B. Brenner. 2005. CD1a-, b-, and c-restricted TCRs recognize both self and foreign antigens. J. Immunol. 175:6344-6351. http://dx.doi.org/10.4049/jimmunol.175.10.6344
62. Wanders, R.J., S. Ferdinandusse, P. Brites, and S. Kemp. 2010. Peroxisomes, lipid metabolism and lipotoxicity. Biochim. Biophys. Acta. 1801:272-280. http://dx.doi.org/10.1016/j.bbalip.2010.01.001
63. Wingard, J.R., N.S. Majhail, R. Brazauskas, Z. Wang, K.A. Sobocinski, D. Jacobsohn, M.L. Sorror, M.M. Horowitz, B. Bolwell, J.D. Rizzo, and G. Socié. 2011. Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J. Clin. Oncol. 29:2230-2239. http://dx.doi.org/10.1200/JCO.2010.33.7212
64. Wu, D.Y., N.H. Segal, S. Sidobre, M. Kronenberg, and P.B. Chapman. 2003. Cross-presentation of disialoganglioside GD3 to natural killer T cells. J. Exp. Med. 198:173-181. http://dx.doi.org/10.1084/jem.20030446
65. Wu, D., G.W. Xing, M.A. Poles, A. Horowitz, Y. Kinjo, B. Sullivan, V. Bodmer-Narkevitch, O. Plettenburg, M. Kronenberg, M. Tsuji, et al. 2005. Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cells. Proc. Natl. Acad. Sci. USA. 102:1351-1356. http://dx.doi.org/10.1073/pnas.0408696102
66. Zhao, Z., and Y. Xu. 2010. An extremely simple method for extraction of lysophospholipids and phospholipids from blood samples. J. Lipid Res. 51:652-659. http://dx.doi.org/10.1194/jlr.D001503